Quantitative Risk Map Decision-Support System in Diagnosing Prostate Cancer in Patients Undergoing Magnetic Resonance Imaging and Biopsy

Inclusion Criteria

• Patients with known or suspected prostate cancer who have been referred to the Department of Radiology at the University of Chicago Medical Center for a diagnostic MRI exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate
• Written informed consent will be signed by the patients before the MRI examination

Exclusion Criteria

• Subjects will be screened and excluded per standard clinical protocol
• Subjects incapable of giving informed written consent
• Subjects who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher
• Subjects with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders
• Prisoners
• Minor children (under the age of 18 years old)
• Previous treatments (surgery, radiation, focal ablation, hormone or other chemotherapy) for prostate cancer